To the editor: The Pim (for provirus integration site for Moloney murine leukemia virus) family of serine/threonine kinases are strongly involved in oncogenic processes and efforts are ongoing to develop specific Pim kinase inhibitors as anti-cancer therapy.[1][1] Interestingly, recent reports from
No takes yet. Share an insight, caveat, or question.
Green et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: